72 related articles for article (PubMed ID: 7951047)
1. cDNA sequence identity for the type I interferon receptor subunit from cell lines of widely differing responsiveness to interferon.
Payne MJ; Ralph SJ; De Veer MJ; Allen K; Linnane AW; Devenish RJ
Biochem Mol Biol Int; 1994 May; 33(2):283-8. PubMed ID: 7951047
[TBL] [Abstract][Full Text] [Related]
2. Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta.
Jiang H; Lin JJ; Tao J; Fisher PB
Oncogene; 1997 Jan; 14(4):473-80. PubMed ID: 9053844
[TBL] [Abstract][Full Text] [Related]
3. The down-regulation of alpha-interferon receptors in human lymphoblastoid cells: relation to cellular responsiveness to the antiproliferative action of alpha-interferon.
Pfeffer LM; Donner DB
Cancer Res; 1990 May; 50(9):2654-7. PubMed ID: 2139358
[TBL] [Abstract][Full Text] [Related]
4. Identification and expression analysis of cDNAs encoding channel catfish type I interferons.
Long S; Milev-Milovanovic I; Wilson M; Bengten E; Clem LW; Miller NW; Chinchar VG
Fish Shellfish Immunol; 2006 Jul; 21(1):42-59. PubMed ID: 16426862
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
[TBL] [Abstract][Full Text] [Related]
6. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
Chawla-Sarkar M; Leaman DW; Borden EC
Clin Cancer Res; 2001 Jun; 7(6):1821-31. PubMed ID: 11410525
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the expression of the IFN-gamma receptor beta-chain controls responsiveness to IFN-gamma in human peripheral blood T cells.
Sakatsume M; Finbloom DS
J Immunol; 1996 Jun; 156(11):4160-6. PubMed ID: 8666783
[TBL] [Abstract][Full Text] [Related]
8. Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation.
Janji B; Melchior C; Vallar L; Kieffer N
Oncogene; 2000 Jun; 19(27):3069-77. PubMed ID: 10871859
[TBL] [Abstract][Full Text] [Related]
9. p95(vav) associates with the type I interferon (IFN) receptor and contributes to the antiproliferative effect of IFN-alpha in megakaryocytic cell lines.
Micouin A; Wietzerbin J; Steunou V; Martyré MC
Oncogene; 2000 Jan; 19(3):387-94. PubMed ID: 10656686
[TBL] [Abstract][Full Text] [Related]
10. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antiproliferative effects of glucocorticoids and interferon-alpha on some lymphoid cell lines.
Elliott KR; Princler GL; Urba WJ; Faltynek CR
J Cell Physiol; 1988 Jan; 134(1):85-92. PubMed ID: 3335582
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles in human mesothelioma cell lines in response to interferon-gamma treatment.
Kettunen E; Vivo C; Gattacceca F; Knuutila S; Jaurand MC
Cancer Genet Cytogenet; 2004 Jul; 152(1):42-51. PubMed ID: 15193440
[TBL] [Abstract][Full Text] [Related]
13. Identification of multiple mRNA and DNA sequences from small tissue samples isolated by laser-assisted microdissection.
Bernsen MR; Dijkman HB; de Vries E; Figdor CG; Ruiter DJ; Adema GJ; van Muijen GN
Lab Invest; 1998 Oct; 78(10):1267-73. PubMed ID: 9800952
[TBL] [Abstract][Full Text] [Related]
14. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
15. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display.
van Groningen JJ; Bloemers HP; Swart GW
Cancer Res; 1995 Dec; 55(24):6237-43. PubMed ID: 8521420
[TBL] [Abstract][Full Text] [Related]
16. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
[TBL] [Abstract][Full Text] [Related]
17. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
[TBL] [Abstract][Full Text] [Related]
18. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF.
Liu B; Earl HM; Baban D; Shoaibi M; Fabra A; Kerr DJ; Seymour LW
Biochem Biophys Res Commun; 1995 Dec; 217(3):721-7. PubMed ID: 8554590
[TBL] [Abstract][Full Text] [Related]
19. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
